Associated Papers
Genotype-Phenotype Features of Germline Variants of the TMEM127 Pheochromocytoma Susceptibility Gene: A 10-Year Update.
Armaiz-Pena G et al.
The Journal of Clinical Endocrinology and Metabolism, 2021
Functional Characterization of TMEM127 Variants Reveals Novel Insights into Its Membrane Topology and Trafficking.
Flores SK et al.
The Journal of Clinical Endocrinology and Metabolism, 2020
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.
Bausch B et al.
Jama Oncology, 2017
TMEM127 screening in a large cohort of patients with pheochromocytoma and/or paraganglioma.
Abermil N et al.
The Journal of Clinical Endocrinology and Metabolism, 2012
Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites.
Neumann HP et al.
The Journal of Clinical Endocrinology and Metabolism, 2011
Select a paper to view details